These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18341845)

  • 21. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.
    Fernández J; Navasa M; Planas R; Montoliu S; Monfort D; Soriano G; Vila C; Pardo A; Quintero E; Vargas V; Such J; Ginès P; Arroyo V
    Gastroenterology; 2007 Sep; 133(3):818-24. PubMed ID: 17854593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Primary prophylaxis of spontaneous bacterial peritonitis].
    Soriano G; Guarner C
    Gastroenterol Hepatol; 1997; 20(6):312-4. PubMed ID: 9296848
    [No Abstract]   [Full Text] [Related]  

  • 23. A pill a day can improve survival in patients with advanced cirrhosis.
    Runyon BA
    Gastroenterology; 2007 Sep; 133(3):1029-31. PubMed ID: 17854604
    [No Abstract]   [Full Text] [Related]  

  • 24. Peritoneal dialysis-related peritonitis caused by Gemella morbillorum in a patient with systemic lupus erythematosus receiving steroid therapy.
    Lai CC; Wu CH; Chen JT; Hsueh PR
    J Microbiol Immunol Infect; 2008 Jun; 41(3):272-4. PubMed ID: 18629424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An economic analysis of norfloxacin prophylaxis against spontaneous bacterial peritonitis.
    Younossi ZM; McHutchison JG; Ganiats TG
    J Hepatol; 1997 Aug; 27(2):295-8. PubMed ID: 9288603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Norfloxacin modulates the inflammatory response and directly affects neutrophils in patients with decompensated cirrhosis.
    Zapater P; Caño R; Llanos L; Ruiz-Alcaraz AJ; Pascual S; Barquero C; Moreu R; Bellot P; Horga JF; Muñoz C; Pérez J; García-Peñarrubia P; Pérez-Mateo M; Such J; Francés R
    Gastroenterology; 2009 Nov; 137(5):1669-79.e1. PubMed ID: 19660462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis.
    Dupeyron C; Mangeney N; Sedrati L; Campillo B; Fouet P; Leluan G
    Antimicrob Agents Chemother; 1994 Feb; 38(2):340-4. PubMed ID: 8192461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and the immunomodulatory effect of rifaximin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic Egyptian patients.
    Mostafa T; Badra G; Abdallah M
    Turk J Gastroenterol; 2015 Mar; 26(2):163-9. PubMed ID: 25835116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial.
    Yim HJ; Suh SJ; Jung YK; Yim SY; Seo YS; Lee YR; Park SY; Jang JY; Kim YS; Kim HS; Kim BI; Um SH
    Am J Gastroenterol; 2018 Aug; 113(8):1167-1176. PubMed ID: 29946179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial.
    Singh N; Gayowski T; Yu VL; Wagener MM
    Ann Intern Med; 1995 Apr; 122(8):595-8. PubMed ID: 7887554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bacterial infections in liver cirrhosis].
    Papp M; Farkas A; Udvardy M; Tornai I
    Orv Hetil; 2007 Mar; 148(9):387-95. PubMed ID: 17344166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Spontaneous bacterial peritonitis- undervalued complication in liver cirrhosis].
    Prelipcean CC
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):682-4. PubMed ID: 12092220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotics for prophylaxis of spontaneous bacterial peritonitis: systematic review & Bayesian network meta-analysis.
    Soni H; Kumar-M P; Sharma V; Bellam BL; Mishra S; Mahendru D; Mandavdhare HS; Medhi B; Dutta U; Singh V
    Hepatol Int; 2020 May; 14(3):399-413. PubMed ID: 32266675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Norfloxacin-induced acute cholestatic hepatitis in a patient with alcoholic liver cirrhosis.
    Romero-Gómez M; Suárez García E; Fernández MC
    Am J Gastroenterol; 1999 Aug; 94(8):2324-5. PubMed ID: 10445586
    [No Abstract]   [Full Text] [Related]  

  • 35. Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis?
    Schubert ML; Sanyal AJ; Wong ES
    Gastroenterology; 1991 Aug; 101(2):550-2. PubMed ID: 1906029
    [No Abstract]   [Full Text] [Related]  

  • 36. Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial.
    Grangé JD; Roulot D; Pelletier G; Pariente EA; Denis J; Ink O; Blanc P; Richardet JP; Vinel JP; Delisle F; Fischer D; Flahault A; Amiot X
    J Hepatol; 1998 Sep; 29(3):430-6. PubMed ID: 9764990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous bacterial peritonitis: prevention and therapy.
    Hoefs JC
    Hepatology; 1990 Oct; 12(4 Pt 1):776-81. PubMed ID: 2210680
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary prophylaxis of SBP.
    Menon S
    Gastroenterology; 2008 Feb; 134(2):643-4; author reply 644. PubMed ID: 18242238
    [No Abstract]   [Full Text] [Related]  

  • 39. A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients.
    Lontos S; Shelton E; Angus PW; Vaughan R; Roberts SK; Gordon A; Gow PJ
    J Dig Dis; 2014 May; 15(5):260-7. PubMed ID: 24612987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocarditis caused by Gemella morbillorum resistant to beta-lactams and aminoglycosides.
    Kofteridis DP; Anastasopoulos T; Panagiotakis S; Kontopodis E; Samonis G
    Scand J Infect Dis; 2006; 38(11-12):1125-7. PubMed ID: 17148095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.